Semaglutide, though also causing gastrointestinal issues, typically results in fewer and less severe side effects
Month 4: Steady Progress (1 mg dose) Average weight loss: 6-8% cumulative (12-16 pounds for a 200-pound person) Around week 12-16, your provider will increase your dose to 1 mg weekly
Semaglutide (Wegovy, Ozempic, Rybelsus) is an FDA-approved medicine used for chronic weight management in individuals who are overweight or with general obesity with at least one weight-related disorder (such as type 2 diabetes, high cholesterol, or high blood pressure) in addition to increased physical activity or a reduced calorie diet
You can get Mounjaro in six strengths : 2.5 mg 5 mg 7.5 mg 10 mg 12.5 mg 15 mg Your clinician will always give you the lowest dose (2.5 mg) to begin with, so you're less likely to experience side effects
PlexusDx's Precision Peptide Genetic Test examines predisposition variants in key peptide pathways, which can provide context about your individual sensitivity profile before starting semaglutide
